Health - Google News: Most Work Stops on Major Alzheimer's Drug

Tuesday, August 7, 2012

Health - Google News

Google News

Aug 6th 2012, 22:31

Most Work Stops on Major Alzheimer's Drug
MedPage Today
By John Gever, Senior Editor, MedPage Today In the wake of another negative trial with the anti-amyloid biologic drug bapineuzumab, Pfizer and Janssen said they were halting development of the product for mild to moderate Alzheimer's disease.
Pfizer, J&J scrap Alzheimer's drug after study failsReuters
The Bapi Bust: Pfizer & J&J Shut Down Alzheimer's Phase 3 ProgramForbes
Pfizer, Johnson & Johnson To Stop Trials of Alzheimer's DrugWall Street Journal
Businessweek -Boston.com
all 204 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in:

Paparazziii